Ulf Ludwig will resign from the Board of Management

MEDICLIN startet well into the FY 2019

MEDICLIN will continue to grow – about 50 Millionen Euros will be invested

MEDICLIN increased its Group sales by about 6 % - Preliminary Group EBIT amounts to EUR 15.1 mill.

Ad hoc-Release Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014: Preliminary Group EBIT mainly burdened by one-off effects – preliminary Group sales meets forecast

MEDICLIN is satisfied with the business development of the first nine months of 2018

MEDICLIN increased Group sales by 7.5 % in the first half year of 2018 compared to prior-year period

The shareholders’ of MEDICLIN Aktiengesellschaft expressed their satisfaction with the business development in 2017 at today's Annual General Meeting

MEDICLIN started well into the 2018 financial year

MEDICLIN grew significantly in 2017 − Management Board will propose the distribution of a dividend for the 2017 FY to the Annual General Meeting in May